February 11, 2017
Pfizer Inc. (NYSE:PFE), NYSE:PFE

Pfizer to Pull Out of Adelaide by 2021

Pharmaceutical giant Pfizer announced that it will close its manufacturing plant in Adelaide, Australia by the end of 2021. The announcement came despite plans being announced less than 12 […]
February 6, 2017
stocks to watch out for

3 Stocks to Watch Out For This Week

3 Stocks to Watch Out For This Week   Markets are experiencing political upheavals this week. Global stock markets are patiently waiting for next move from Trump. […]
August 23, 2016
foreign stocks

2 Pharma Stocks Rally on Monday Following Pfizer Deal

Pfizer’s (PFE) announcement that the company will purchase Medivation (MDVN) in a deal worth $14 billion acquisition caused the IBB, the largest Nasdaq biotech ETF, to […]
July 27, 2016

4 Figures Investors Need to Know From Johnson & Johnsons Q2 Earnings Report

Johnson & Johnson (JNJ) released their Q2 earnings report earlier in the week last week, and investors in the company will need to take a close […]
June 16, 2016
valeant hq

2 Bargain Healthcare Stocks to Buy

Healthcare stocks have taken a beating this year, but there are still bargains to be had. These two stocks may be ready to make a comeback: […]
June 15, 2016

3 Cancer Drug Developers to Watch in the Second-half of the Year

Cancer therapies are being released in swarms, and global spending on cancer medicines reached $107 billion last year. Estimates have this figure increasing to $150 billion […]
May 30, 2016
Pfizer Headquarters

2 Big Pharma Stocks to Buy on the Cheap

The pharmaceutical industry is down even further than the energy sector in 2016, with several big pharma stocks trading low compared to their forward earnings. Two […]
April 6, 2016
Pfizer Headquarters

Pfizer, Allergan Deal is the First Casualty of U.S. Tax Rule Changes

If you were betting on the Pfizer (PFE), Allergan (AGN) deal going through, you woke up to some disappointing news this morning. Pfizer confirmed this morning […]
March 21, 2016
valeant hq

Pearson to Step Down as Valeant CEO, Bill Ackman Added to Board

Valeant Pharmaceuticals International Inc.’s (VRX) CEO, Mike Pearson, will step down in a shakeup of the company’s board and management. The move comes after a series […]